ScholarIQanswers from OpenAlex & ORCID
Shah‐Jalal Sarker
ResearcherPublications, citations & collaboration network
Shah‐Jalal Sarker is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Shah‐Jalal Sarker have?
ScholarIQindexed works
Shah‐Jalal Sarker has 77 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Shah‐Jalal Sarker have?
ScholarIQcitation count
Shah‐Jalal Sarker has 1,798 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Shah‐Jalal Sarker?
ScholarIQh-index
Shah‐Jalal Sarker has an h-index of 20 in OpenAlex.
What is the i10-index of Shah‐Jalal Sarker?
ScholarIQi10-index
Shah‐Jalal Sarker has an i10-index of 28 in OpenAlex.
What is the ORCID of Shah‐Jalal Sarker?
ScholarIQorcid
The ORCID for Shah‐Jalal Sarker is on the source record.
What is the OpenAlex record for Shah‐Jalal Sarker?
ScholarIQopenalex
The OpenAlex for Shah‐Jalal Sarker is on the source record.
What are the most-cited papers on Shah‐Jalal Sarker?
ScholarIQmost cited works
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
Peter Schmid, Jacinta Abraham, Stephen Chan, Duncan Wheatley, Adrian Murray Brunt, Gia Nemsadze, Richard D. Baird, Yeon Hee Park, Peter S Hall, Timothy Perren, Robert C. Stein, László Mangel, Jean-Marc Ferrero, Melissa Phillips, John Conibear, Javier Cortés, Andrew Foxley, Elza C. de Bruin, Robert McEwen, Daniel Stetson, Brian Dougherty, Shah‐Jalal Sarker, Aaron Prendergast, Max McLaughlin-Callan, Matthew Burgess, Cheryl Lawrence, Hayley Cartwright, Kelly Mousa, Nicholas C. Turner
A Randomized Prospective Study Comparing Acquisition of Laparoscopic Skills in Three‐Dimensional (3D) vs. Two‐Dimensional (2D) Laparoscopy
B. Alaraimi, W. El Bakbak, Shah‐Jalal Sarker, S. Makkiyah, Ahmad Almarzouq, Richie Goriparthi, Amina Bouhelal, Vincent Quan, Bijendra Patel
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
Thomas Powles, Matthew Wheater, Omar Din, T. Geldart, Ekaterini Boleti, Andrew Stockdale, Santhanam Sundar, Angus Robinson, Imtiaz Ahmed, Akhila Wimalasingham, Wendy Burke, Shah‐Jalal Sarker, Syed A. Hussain, Christy Ralph
Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation
Vishal Vyas, Hazel Blythe, Elizabeth G. Wood, Balraj Sandhar, Shah‐Jalal Sarker, Damian Balmforth, Shirish G. Ambekar, John Yap, Steve Edmondson, Carmelo Di Salvo, Kit Wong, Neil Roberts, Rakesh Uppal, Ben G. Adams, Alex Shipolini, Aung Oo, David Lawrence, Shyam Kolvekar, Kulvinder Lall, Malcolm Finlay, M. Paula Longhi
A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).
Thomas Powles, Alejo Rodríguez‐Vida, Ignacio Durán, Simon J. Crabb, Michiel Simon Van Der Heijden, Albert Font Pous, Gwénaëlle Gravis, Urbano Anido Herranz, Andrew Protheroe, Alain Ravaud, Denis Maillet, María José Méndez-Vidal, Cristina Suárez, Anja Lorch, Cora N. Sternberg, Mark Linch, Shah‐Jalal Sarker, Aaron Prendergast, Kelly Mousa, Daniel Castellano